- News
- World
- Americas
- US politics
The changes are set to take effect in January 2027.
Brendan RasciusIn New YorkWednesday 26 November 2025 13:23 GMTComments
CloseTrump denies he pushed two-year Obamacare subsidies extension
Sign up for the daily Inside Washington email for exclusive US coverage and analysis sent to your inbox
Get our free Inside Washington email
Get our free Inside Washington email
Email*SIGN UPI would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
President Donald Trump’s administration announced that Medicare will pay reduced prices for 15 prescription drugs, including weight-loss and cancer medications.
On Tuesday, the Centers for Medicare & Medicaid Services revealed that the reduced drug prices are expected to save the government about $12 billion on Medicare spending compared with last year.
“President Trump directed us to stop at nothing to lower health care costs for the American people,” Health and Human Services Secretary Robert F. Kennedy, Jr. said in a news release. “As we work to Make America Healthy Again, we will use every tool at our disposal to deliver affordable health care to seniors.”
The new “maximum fair prices” for the drugs will take effect on January 1, 2027, raising the total number of medications with negotiated prices to 25 when added to the 10 announced by former President Joe Biden’s administration last year.
The Trump administration announced that Medicare will pay lower prices for 15 drugs, including weight-loss and cancer medications. (AFP/Getty)“This year’s results stand in stark contrast to last year’s,” CMS Administrator Mehmet Oz said. “Using the same process with a bolder direction, we have achieved substantially better outcomes for taxpayers.”
Among the drugs included in the program are weight-loss drugs Ozempic and Wegovy and cancer drugs Xtandi, Pomalyst, Ibrance.
The others are: Trelegy Ellipta, Ofev, Linzess, Calquence, Austedo and Austedo XR, Breo Ellipta, Tradjenta, Xifaxan, Vraylar, Janumet and Janumet XR and Otezla.
More about
MedicaidOzempicCancer drugsTrumpJoin our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments
